An IPT (short for Intellectual Property Token) is a digital token that represents ownership, licensing rights, or financial interest in a specific piece of intellectual property—typically a patent, research asset, or therapeutic development—in a blockchain-based ecosystem.

In the context of VitaDAO, an IPT is used to:

• Tokenize early-stage biotech research so it can be transparently funded, governed, and commercialized by a decentralized community.
• Represent rights to IP, such as licensing revenue, equity in spin-outs, or downstream royalties.
• Enable fractional ownership, allowing multiple stakeholders—scientists, funders, and contributors—to participate in and benefit from the development of longevity-focused therapeutics.
• Align incentives by giving token holders governance power and economic interest in the success of the project.

VitaLabs incubates high-risk, high-reward longevity science by fully funding and de-risking bold early-stage research in-house—laying a strong scientific foundation before minting an IP token (IPT) to represent the resulting intellectual property.

For externally developed projects, VitaDAO takes a complementary approach: validated, late-stage innovations launch directly as IPTs, enabling the community to collectively fund their final push toward clinical translation and commercialization. This dual-track model ensures that both breakthrough discoveries and mature biotech assets receive the tailored support they need to reach the public.